PubMed Nucleotide Protein Genome Structure PopSet Taxonomy OMIM
The OMIM Gene map presents the cytogenetic map location of disease genes and other expressed genes described in OMIM. See the OMIM Morbid Map for a list of disease genes organized by disease. For more refined maps of genes and DNA segments click on the Location to invoke NCBI Entrez Map Viewer.
Search for: (from the current location)    
  • Enter gene symbol, chromosomal location, or disorder keyword to search for, e.g. "CYP1", "5", "1pter", "Xq", or "alzheimer".
  • You must capitalize X and Y to search for those chromosomes.
5pter-p15.33, NDUFS6 to 5p15.33-p13.1, MCDR3 <<Move Up Move Down>>
Location Symbol Title MIM # Disorder Comments Method Mouse
5pter-p15.33 NDUFS6 NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kD   603848 Complex I, mitochondrial respiratory chain, deficiency of, 252010 (3)   R  
5pter-q11 RARS Arginyl-tRNA synthetase   107820   very close to LARS S  
5p15.3 ADCY2 Adenylyl cyclase-2, brain   103071     A, REa 13(Adcy2)
5p15.3 AHRR, KIAA1234 Arylhydrocarbon receptor repressor   606517     R, A 13(Ahrr)
5p15.3 IRX1 Iroquois homeo box protein 1   606197     A  
5p15.3 IRX2 Iroquois homeo box protein 2   606198     A  
5p15.3 IRX4 Iroquois homeobox protein 4   606199     REa, R, H 13(Irx4)
5p15.3 MRPL36 Mitochondrial ribosomal protein L36   611842     REc  
5p15.3 SLC12A7, KCC4 Solute carrier family 12 (potassium/chloride transporters), member 7   604879     R, REa  
5p15.3 SLC6A3, DAT1 Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 126455 {Attention-deficit hyperactivity disorder, susceptibility to}, 143465(2); {Nicotine dependence, protection against}, 188890 (3); {Major affective disorder}, 125480 (3)   Psh, A, Fd 13(Dat1)
5p15.3 SLC9A3, NHE3 Solute carrier family 9 (sodium/hydrogen exchanger), member 3   182307   pseudogene on chr.10 REa, Fd 13(Slc9a3)
5p15.3 TPPP, P25, P24 Tubulin polymerization-promoting protein   608773     Psh, R  
5p15.33 BCC3 Basal cell carcinoma, susceptibility to, 3   613059 {Basal cell carcinoma, susceptibility to, 3} (2)   Fd  
5p15.33 CLPTM1L, CRR9 CLPTM1-like protein   612585     REc  
5p15.33 GLM8 Glioma susceptibility 8   613033 {Glioma susceptibility 8} (2) associated with rs2736100 Fd  
5p15.33 LNCR3 Lung cancer susceptibility 3   612571 {Lung cancer susceptibility 3} (2) associated with rs402710 and rs2736100 Fd  
5p15.33 SLC6A18, XTRP2 Solute carrier family 6 (neurotransmitter transporter), member 18   610300     REc  
5p15.33 SLC6A19, HND Solute carrier family 6 (neurotransmitter transporter), member 19   608893 Hartnup disorder, 234500 (3)   REc, Fd 13(Slc6a19)
5p15.33 TERT, TCS1, EST2 Telomerase reverse transcriptase   187270 {Aplastic anemia, susceptibility to}, 609135 (3); {Pulmonaryfibrosis,idiopathic, susceptibility to}, 178500 (3); Dyskeratosis congenita, 127550 (3) deleted in cri du chat R, D  
5p15.33-p15.2 MYP16 Myopia 16   612554 Myopia 16 (2) max lod at D5S2505 Fd  
5p15.33-p13.1 MCDR3 Macular dystrophy, retinal, 3   608850 Macular dystrophy, retinal, 3 (2) maximum lod at D5S630 Fd  
Copyright © 1966-2009 Johns Hopkins University <<Move Up Move Down>>

Disclaimer | Write to the Help Desk | Privacy Policy
NCBI | NLM | NIH